State of Wisconsin Investment Board
URGN icon

State of Wisconsin Investment Board’s UroGen Pharma URGN Stock Holding History

State of Wisconsin Investment Board’s Portfolio URGN Stock Details URGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$577K Buy
+32,116
New +$644K ﹤0.01% 1924
2023
Q3 		– Sell
-15,200
Closed -$157K – 2591
2023
Q2 		$157K Sell
15,200
-22,400
-60% -$247K ﹤0.01% 2184
2023
Q1 		$347K Sell
37,600
-13,600
-27% -$125K ﹤0.01% 2023
2022
Q4 		$454K Sell
51,200
-8,400
-14% -$79.6K ﹤0.01% 1933
2022
Q3 		$496K Sell
59,600
-15,100
-20% -$125K ﹤0.01% 1987
2022
Q2 		$612K Buy
74,700
+34,508
+86% +$237K ﹤0.01% 1970
2022
Q1 		$350K Buy
+40,192
New +$313K ﹤0.01% 2056
2021
Q2 		– Sell
-30,427
Closed -$593K – 2164
2021
Q1 		$593K Buy
30,427
+858
+3% +$18.2K ﹤0.01% 1536
2020
Q4 		$533K Sell
29,569
-5,075
-15% -$106K ﹤0.01% 1516
2020
Q3 		$668K Buy
34,644
+2,320
+7% +$52.5K ﹤0.01% 1392
2020
Q2 		$844K Buy
32,324
+1,901
+6% +$46.5K ﹤0.01% 1276
2020
Q1 		$543K Buy
30,423
+2,323
+8% +$62.8K ﹤0.01% 1327
2019
Q4 		$938K Hold
28,100
– – ﹤0.01% 1259
2019
Q3 		$670K Buy
+28,100
New +$919K ﹤0.01% 1241

Other funds holding URGN

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

State of Wisconsin Investment Board's URGN Position: Q1 2026 in Review

State of Wisconsin Investment Board opened a new position in UroGen Pharma (URGN) in Q1 2026: 32,116 shares worth $577K. The stake represents ﹤0.01% of the portfolio and ranks #1924 among its holdings. This is a return to the name: State of Wisconsin Investment Board previously reported a position in URGN as recently as Q2 2023.

State of Wisconsin Investment Board first reported a position in URGN in Q3 2019 and has held it in 14 quarters since. The position peaked at $938K in Q4 2019. 173 funds tracked by Wall St. Rank hold URGN as of Q1 2026.

  • State of Wisconsin Investment Board held 32,116 shares of UroGen Pharma worth $577K as of Q1 2026.
  • UroGen Pharma was a new State of Wisconsin Investment Board position in Q1 2026.
  • UroGen Pharma made up ﹤0.01% of State of Wisconsin Investment Board's portfolio in Q1 2026, its #1924 holding.
  • State of Wisconsin Investment Board first reported a position in UroGen Pharma in Q3 2019 and has held it in 14 quarters since.
  • State of Wisconsin Investment Board's UroGen Pharma position peaked at $938K in Q4 2019.
  • 173 funds tracked by Wall St. Rank held UroGen Pharma as of Q1 2026.

Based on State of Wisconsin Investment Board's 13F filing for Q1 2026, filed 15 May 2026.